Clinical Trials Logo

Clinical Trial Summary

The purpose of this study is to study the use of a drug, tranexamic acid (TXA) to decrease bleeding and fluid collections in patients undergoing excision of excess lower abdominal skin and soft tissue, otherwise known as a panniculectomy. The use of TXA in this study is experimental. TXA is a medication currently used in many surgical subspecialties to control bleeding. TXA is approved by the FDA as a medication taken by mouth for the treatment of heavy menstrual bleeding and as an injection in patients with hemophilia for short-term use (two to eight days) to reduce or prevent hemorrhage and reduce the need for replacement therapy during and following tooth extraction. The use of TXA in this study is experimental, which means it is not approved by the FDA for topical use in decreasing bleeding during and after surgery. The results of this study will help the researchers determine if TXA is effective in decreasing blood loss following surgery. If effective, researchers hope this will result in earlier removal of post-operative drains leading to faster return to work or social activities


Clinical Trial Description

Participants consented to take part in this study will be assigned by chance to receive either placebo (Group 1) or TXA (Group 2) during the surgical procedure. This study will be double-blinded, in that neither the patient nor the surgeon will know to which treatment, (placebo vs. TXA) that the patient will receive. Participating patients will be randomized to receive normal saline (control group) or tranexamic acid (study population) on the day of surgery by the pharmacist. Normal saline is the current standard of care. Double blinding ensures that the researcher or the patient's opinion does not influence study results, however this information is available from the pharmacy in the event of any complications. Each group will have 10 participants. The solution of either saline or TXA will be placed into a sterile bowl in the operating area and three lap sponges will be placed in the solution at the beginning of the procedure. Group 1 will undergo application of three normal saline soaked lap sponges to the surgical site. Group 2 will undergo application of three TXA soaked lap sponges to the surgical site. The lap sponges will be removed after three minutes and measurements will be taken for the study. After discharge, post-operative drain output will be monitored and recorded by the patient on a provided drain documentation sheet. This does not differ from the current standard of care regarding drain output recordings. All patients who receive a post-surgical drain are asked to document output. All patients will be educated on routine drain care and recording drain output. Patients will not need to undergo any extra medical tests, medical procedures or doctor visits if they decide to join the study. Patient participation in the study begins upon signature of the consent form and is expected to last no more than 8 weeks following the patient's surgical procedure. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT04902950
Study type Interventional
Source The Reading Hospital and Medical Center
Contact
Status Terminated
Phase Phase 4
Start date August 17, 2020
Completion date May 6, 2021

See also
  Status Clinical Trial Phase
Completed NCT03143959 - Functional Improvement With Abdominoplasty N/A
Active, not recruiting NCT04207047 - Histologic Evaluation of Tissue Following Lutronic System Exposure N/A
Active, not recruiting NCT04712331 - Effect of Abdominal Exercises and Russian Stimulation on The Abdominal Muscles Strength After Abdominoplasty N/A
Completed NCT02949778 - Quadratus Lumborum Block for Abdominoplasty Phase 4
Active, not recruiting NCT01026662 - In-vivo Analysis of a Fractional CO2 Laser System (eMatrixCO2) Intended for Treatment of Soft Tissue Phase 2/Phase 3
Withdrawn NCT03770195 - Registry Study for the Use of HEMOBLAST™ Bellows in Abdominoplasty
Terminated NCT03429556 - Study to Evaluate Botulinum Neurotoxin Serotype E (EB-001) in Reducing Musculoskeletal Pain in Abdominoplasty Phase 2
Terminated NCT02302222 - The Management of Closed Surgical Incisions Resulting From Incisional Hernia Repair and/or Functional Panniculectomy Using the Prevena™ Customizable™ Dressing N/A
Recruiting NCT05939518 - Fluid Therapy and Glycocalyx Shedding During Moderate Surgery N/A
Active, not recruiting NCT05490602 - Comparison Study in Different Sutures Techniques in Reduction of Known Abdominoplasty Complications and Improving Patients' Post-operative Outcomes
Completed NCT01389635 - Abdominoplasty Under Epidural Anesthesia N/A
Recruiting NCT04670224 - Efficiency of the Quadratus Lumborum Block for Post-operative Analgesia in Abdominoplasty Surgery N/A
Recruiting NCT03190876 - Seroma Prevention After Body Contouring Procedures N/A
Recruiting NCT04787874 - Effect of Prehabilitation on Surgical Outcomes of Abdominally-based Plastic Surgery Procedures N/A
Completed NCT01604694 - Ultrasound-guided Transversus Abdominis Plane Block for Analgesia After Abdominoplasty Phase 4
Withdrawn NCT02140385 - Role of Preservation of Scarpa's Fascia in Abdominoplasty N/A
Completed NCT04182880 - Evaluate the Safety and Pharmacokinetic Profile of CPL-01 in the Management of Acute Postoperative Pain Phase 2
Completed NCT03467724 - Treatment of Surgical Scars Following Breast Augmentation, Abdominoplasty or Face Lift N/A
Not yet recruiting NCT02930447 - Evaluation of the Benefit of the Use of Autologous Glue Prepared With RegenKit®-Surgery Device in Abdominoplasty N/A
Enrolling by invitation NCT06043557 - Patient Satisfaction and Reflection on Drain Placement N/A